Frontiers in Microbiology (Feb 2022)

Respiratory Mucosal Immunity: Kinetics of Secretory Immunoglobulin A in Sputum and Throat Swabs From COVID-19 Patients and Vaccine Recipients

  • Cuiping Ren,
  • Cuiping Ren,
  • Cuiping Ren,
  • Cuiping Ren,
  • Cuiping Ren,
  • Yong Gao,
  • Cong Zhang,
  • Cong Zhang,
  • Cong Zhang,
  • Cong Zhang,
  • Cong Zhang,
  • Chang Zhou,
  • Chang Zhou,
  • Chang Zhou,
  • Chang Zhou,
  • Chang Zhou,
  • Ying Hong,
  • Mingsheng Qu,
  • Mingsheng Qu,
  • Mingsheng Qu,
  • Mingsheng Qu,
  • Mingsheng Qu,
  • Zhirong Zhao,
  • Yinan Du,
  • Yinan Du,
  • Yinan Du,
  • Yinan Du,
  • Yinan Du,
  • Li Yang,
  • Li Yang,
  • Li Yang,
  • Li Yang,
  • Li Yang,
  • Boyu Liu,
  • Boyu Liu,
  • Boyu Liu,
  • Boyu Liu,
  • Boyu Liu,
  • Siying Wang,
  • Siying Wang,
  • Siying Wang,
  • Siying Wang,
  • Siying Wang,
  • Mingfeng Han,
  • Yuxian Shen,
  • Yuxian Shen,
  • Yuxian Shen,
  • Yuxian Shen,
  • Yuxian Shen,
  • Yan Liu,
  • Yan Liu,
  • Yan Liu,
  • Yan Liu,
  • Yan Liu

DOI
https://doi.org/10.3389/fmicb.2022.782421
Journal volume & issue
Vol. 13

Abstract

Read online

While IgM and IgG response to SARS-CoV-2 has been extensively studied, relatively little is known about secretory IgA (sIgA) response in respiratory mucosa. Here we report IgA response to the SARS-CoV-2 in sputum, throat swabs, and serum with nucleocapsid protein (NP) enzyme-linked immunosorbent assays (ELISA) in a cohort of 28 COVID-19 patients and 55 vaccine recipients. The assays showed sIgA in respiratory mucosa could be detected on the first day after illness onset (AIO), and the median conversion time for sIgA in sputum, throat swabs, and serum was 3, 4, and 10 days, respectively. The positive rates of sIgA first week AIO were 100% (24/28) and 85.7% (24/28) in sputum and throat swabs, respectively, and were both 100% during the mid-onset (2–3 weeks AIO). During the recovery period, sIgA positive rates in sputum and throat swabs gradually decreased from 60.7% (17/28) and 57.1% (16/28) 1 month AIO and the sIgA antibodies were all undetectable 6 months AIO. However, serum IgA positive rate was still 100% at 4 months and 53.6% (15/28) at 6 months. Throat swabs obtained from volunteers who received inactivated SARS-CoV-2 vaccines by intramuscular delivery all showed negative results in IgA ELISA. These findings will likely improve our understanding of respiratory mucosal immunity of this emerging disease and help in containing the pandemic and developing vaccines.

Keywords